SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): March 14, 2000
CVS CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 1-1011 05-0494040
(State of incorporation) (Commission (IRS Employer
File no.) Identification No.)
One CVS Drive
Woonsocket, Rhode Island 02895
(Address of principal executive offices including zip code)
Registrant's telephone number, including area code:
(401) 765-1500
NOT APPLICABLE
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events.
CVS Corporation, a Delaware corporation (the "Corporation") has filed its
proxy statement on March 10, 2000 which, as result of the inclusion of the
treasury shares in the calculation made by the transfer agent, indicated that
approximately 402.9 million shares of the Corporation's common stock were
outstanding as of the record date. The correct number for the shares outstanding
as of the record date is approximately 391.8 million.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
CVS CORPORATION
Date: March 14, 2000 By: /s/ David B. Rickard
------------------------------
Name: David B. Rickard
Title: Executive Vice President
and Chief Financial Officer
